Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Earnings Release 2022

May 5, 2022

2543_rns_2022-05-05_8a3b6bfd-64ee-4d67-abc5-2fad3e157b9a.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Current report №18/ 2022 Dated May 5, 2022

NOTIFICATION

"Sopharma" AD (the Company) notifies that for April 2022 the Company recorded an increase in sales of 44% compared to the same month of the previous year, incl. 60% increase in domestic sales and 38% increase in export sales as a result of erratic recovery of activity in major foreign markets.

For the four months since the beginning of the year the revenues from sales of products increase by 34%, incl. 75% increase of sales for the domestic market and 10% increase in export sales.

Ognian Donev